CHMP recommends eight drugs in February – rejects Covid-19 pill
A total of 12 new drugs have now been proposed for full European market clearance in 2023.
by mikkel aabenhus hemmingsen, translated by daniel pedersen
European physicians will likely see their toolboxes expand after the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has held its monthly meeting in February.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
CHMP recommends four drugs in January
For subscribers
Denmark defends controversial Covid-19 pill
For subscribers
FDA approves hemophilia drug from Sobi and Sanofi
For subscribers
.jpg&w=384&q=75)
